• Health
  • Science
  • U.S.
  • Technology
  • Business
  • World
  • Politics
  • Entertainment
  • Sports

Building a Better World

News and information

  • Home
  • Privacy Policy
  • Contact Us
  • Our Team

Alarming disease development sends authorities scrambling

April 29, 2017 By Dan Taylor

Alarming disease development sends authorities scrambling

A major problem has just cropped up that the Centers for Disease Control and Prevention is trying to get a handle on.

A major new problem has just surfaced that is causing concern among U.S. health officials. A new report from the Centers for Disease Control and Prevention indicates that the United States will run out of the vaccine for yellow fever as early as next month, meaning that travelers who need the shot may not be able to go anywhere.

A manufacturing problem appears to be behind the shortage of the only version of the vaccine that is licensed in the U.S., and is often a requirement for countries where mosquito spread diseases are a problem. They may require proof of vaccination in order to enter the country, meaning people without it will be turned back.

It’s been a century since yellow fever was eradicated in the United States, and it’s not a disease people are routinely vaccinated for here. But in many countries where tropical diseases thrive, it’s still a problem. It can cause jaundice, abdominal pain, vomiting, internal bleeding, and organ failure.

“Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine,” the CDC said in a statement. “This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the immunization of U.S. travelers by mid-2017. CDC, the Food and Drug Administration (FDA), and Sanofi Pasteur are collaborating to ensure a continuous yellow fever vaccine supply in the United States. As part of this collaboration, Sanofi Pasteur submitted an expanded access investigational new drug (eIND) application to FDA in September 2016 to allow for the importation and use of an alternative yellow fever vaccine manufactured by Sanofi Pasteur France, with safety and efficacy comparable to the U.S.-licensed vaccine; the eIND was accepted by FDA in October 2016. The implementation of this eIND protocol included developing a systematic process for selecting a limited number of clinic sites to provide the vaccine. CDC and Sanofi Pasteur will continue to communicate with the public and other stakeholders, and CDC will provide a list of locations that will be administering the replacement vaccine at a later date.”

Sharing

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Filed Under: Front Page, Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebookrss

Search:

Recent Posts

  • NASA’s InSight spacecraft makes important course correction May 26, 2018
  • Scientists outraged at latest Trump decision May 15, 2018
  • Huge uproar erupts over major incident at Utah park May 13, 2018
  • Incredible moon discovery stuns scientists May 12, 2018
  • Authorities shocked by discovery about common painkiller May 6, 2018
  • Outrageous crocodile experiment stuns scientists May 5, 2018
  • Great Barrier Reef is too quiet, scientists say May 1, 2018
  • Massive Hiroshima bomb discovery shocks scientists May 1, 2018
  • Earth will be slammed by massive asteroid April 29, 2018
  • Teens are doing something incredibly alarming in schools April 29, 2018
  • Huge discovery in Tasmania stuns scientists April 28, 2018
  • Shocking discovery in New Jersey stuns authorities April 22, 2018
  • Huge volcanic explosion could wipe out the United States April 21, 2018
  • Huge controversy erupts over world’s hottest pepper April 15, 2018
  • SpaceX is about to do something astonishing April 15, 2018

Copyright © 2021 Jones Kilmartin Group, LLC · Metro Pro Theme On Genesis Framework · WordPress